According to Gram Research analysis, a protein called pleiotrophin directly causes fatty liver disease when people eat high-fat diets. In a 2026 study, mice without this protein were protected from weight gain, high blood sugar, and liver damage, even when eating unhealthy food. Researchers found that pleiotrophin promotes fat storage in liver cells, and removing it blocked this process. Female mice showed even stronger protection than males, suggesting sex differences in metabolic response.
Scientists discovered that a protein called pleiotrophin (PTN) plays a major role in causing fatty liver disease when people eat high-fat diets. In a study with mice, researchers found that removing this protein protected animals from weight gain, high blood sugar, and liver damage, even when eating unhealthy food. The findings suggest that blocking pleiotrophin could become a new treatment for metabolic dysfunction-associated fatty liver disease (MASLD), a condition affecting millions of people worldwide. Interestingly, female mice showed even stronger protection than males, suggesting sex differences in how bodies respond to diet.
Key Statistics
A 2026 research study in mice found that deletion of pleiotrophin protected both male and female mice against high-fat diet-induced body weight gain, fasting hyperglycemia, and insulin resistance.
According to research reviewed by Gram, mice lacking pleiotrophin showed prevention of hepatic steatosis (fatty liver), reduced fat accumulation, and protection against liver fibrosis when fed a high-fat diet for 6 months.
A 2026 study found that female mice demonstrated greater protection against the liver-damaging effects of diet-induced obesity compared to male mice when pleiotrophin was deleted.
Research shows that pleiotrophin directly promoted lipid accumulation and fat synthesis in liver cells grown in laboratory dishes, confirming a direct cellular mechanism for the protein’s role in fatty liver disease.
The Quick Take
- What they studied: Whether a protein called pleiotrophin causes fatty liver disease when people eat high-fat diets, and what happens if you remove this protein
- Who participated: Male and female mice (both normal mice and mice genetically engineered to lack the pleiotrophin protein) fed either normal or high-fat diets for 6 months, plus liver cells grown in laboratory dishes
- Key finding: Mice without pleiotrophin were protected from weight gain, high blood sugar, insulin resistance, and fatty liver disease when eating high-fat diets. Female mice showed even greater protection than males.
- What it means for you: This research identifies pleiotrophin as a potential drug target for treating fatty liver disease. However, these are early-stage findings in mice, and human studies would be needed before any new treatments become available. If you have fatty liver disease, current recommendations like weight loss and reducing processed foods remain the best-proven approaches.
The Research Details
Researchers used genetically modified mice to study how pleiotrophin affects liver health. They created two groups: normal mice (with pleiotrophin) and mice lacking the pleiotrophin gene. Both groups were fed either a standard healthy diet or a high-fat diet for 6 months. Scientists measured body weight, blood sugar levels, insulin resistance, liver fat content, and liver damage markers.
To understand how pleiotrophin works at the cellular level, researchers also studied liver cells in laboratory dishes. They added pleiotrophin to cells and measured how much fat accumulated. This helped them confirm that pleiotrophin directly causes cells to store more fat.
The study paid special attention to sex differences, comparing how male and female mice responded to the diets. This is important because men and women sometimes respond differently to diet and disease.
This research approach is powerful because genetic studies in mice let scientists prove that pleiotrophin directly causes disease. By removing the gene entirely, researchers could see what happens without the protein, essentially running a controlled experiment. Testing in both whole animals and isolated cells strengthens the findings by showing the effect works at multiple levels. Examining both sexes reveals important biological differences that could affect how future treatments work in men versus women.
This is original research published in a peer-reviewed scientific journal, meaning other experts reviewed it before publication. The study used multiple approaches (whole animals, cells, and different measurements) to confirm findings, which increases reliability. However, these are mouse studies, not human studies, so results may not directly apply to people. The exact sample size of mice isn’t specified in the abstract, which is a minor limitation. The findings are recent (2026) and represent cutting-edge science.
What the Results Show
Mice lacking pleiotrophin showed remarkable protection against the harmful effects of high-fat diets. These mice gained significantly less weight than normal mice eating the same diet. They also had lower fasting blood sugar levels and better insulin sensitivity, meaning their bodies could control blood sugar more effectively.
Most importantly for liver health, mice without pleiotrophin developed much less fatty liver disease. Their livers accumulated less fat and showed less scarring (fibrosis), which is a sign of advanced liver damage. The protective effect occurred in both male and female mice, though females showed even stronger benefits.
At the cellular level, researchers found that pleiotrophin works by activating specific molecular pathways that promote fat storage in liver cells. When pleiotrophin was removed, these fat-storage pathways were blocked, and cells made less of a protein called DGAT2 that’s essential for storing fat. The study also showed that pleiotrophin affects inflammation throughout the body, which is linked to metabolic disease.
The research revealed that pleiotrophin affects multiple aspects of metabolic health beyond just the liver. Mice without pleiotrophin showed reduced inflammation markers in their blood, suggesting the protein contributes to whole-body inflammation associated with obesity. The study also found that pleiotrophin influences how the body remodels connective tissue in the liver, which is relevant to liver scarring. Additionally, the research identified specific molecular switches (AMPK and AKT signaling) that pleiotrophin controls, providing potential targets for future drug development.
This research builds on previous knowledge that pleiotrophin plays roles in tissue repair and energy metabolism. However, this is the first detailed study of pleiotrophin’s specific role in fatty liver disease. Previous research identified many other proteins involved in liver fat accumulation, but pleiotrophin hadn’t been thoroughly investigated in this context. The finding that removing pleiotrophin protects against metabolic disease is novel and suggests a new therapeutic approach. The observation of sex differences in protection aligns with growing recognition that men and women respond differently to metabolic disease.
The biggest limitation is that this research was conducted in mice, not humans. Mouse studies don’t always translate directly to people because human biology is more complex. The study doesn’t specify the exact number of mice used, making it harder to assess statistical power. The research was conducted in laboratory settings with controlled diets, which differs from real-world eating patterns. The study doesn’t address whether blocking pleiotrophin in adult mice (after disease develops) would help, only whether preventing its function from birth provides protection. Finally, the mechanism by which pleiotrophin affects females differently from males wasn’t fully explained and requires further investigation.
The Bottom Line
Based on this research, pleiotrophin is a promising target for future drug development to treat fatty liver disease. However, no treatments targeting pleiotrophin currently exist for human use. Current evidence-based recommendations for preventing and treating fatty liver disease remain: maintain a healthy weight, eat a balanced diet low in processed foods and added sugars, exercise regularly, and limit alcohol consumption. If you have fatty liver disease, work with your doctor on these proven lifestyle approaches while researchers develop new treatments. Confidence level: High for lifestyle recommendations; Moderate for pleiotrophin as a future therapeutic target.
This research is most relevant to people with fatty liver disease (MASLD or MASH), people at risk for metabolic syndrome, and people struggling with obesity. It’s also important for researchers and pharmaceutical companies developing new treatments. Healthcare providers treating metabolic disease should be aware of this emerging target. People with family histories of liver disease or metabolic problems may find this research encouraging as it points toward new treatment options. However, this research doesn’t yet change recommendations for the general public.
If pleiotrophin-blocking drugs are developed, it typically takes 5-10 years from laboratory discovery to human clinical trials, and another 5-10 years for FDA approval and availability. So realistic timelines for new treatments based on this research would be 10-20 years. In the meantime, proven lifestyle changes can help prevent and manage fatty liver disease today.
Frequently Asked Questions
What is pleiotrophin and why does it cause fatty liver disease?
Pleiotrophin is a protein that tells liver cells to store more fat. In a 2026 mouse study, researchers found that this protein activates molecular pathways that promote fat accumulation in the liver. When the protein was removed, liver cells stored much less fat, preventing fatty liver disease.
Can I get a drug to block pleiotrophin to treat my fatty liver disease?
Not yet. This research identifies pleiotrophin as a promising target, but no approved medications blocking it currently exist. Drug development typically takes 10-20 years from laboratory discovery to availability. Meanwhile, proven treatments include weight loss, reducing processed foods, exercising regularly, and limiting alcohol.
Do these mouse study results apply to humans?
Mouse studies provide important clues about disease mechanisms, but results don’t always translate directly to people. Human clinical trials would be needed to confirm whether blocking pleiotrophin helps people with fatty liver disease. This research is an important first step toward developing new treatments.
Why did female mice show more protection than males in this study?
The study found that female mice were more protected against liver damage from high-fat diets when pleiotrophin was removed, but the exact reason wasn’t fully explained. This suggests sex hormones or other biological differences affect how pleiotrophin influences liver health, an area needing further research.
What should I do right now if I have fatty liver disease?
Focus on proven strategies: lose weight if overweight, eat a diet rich in vegetables and whole grains while limiting processed foods and added sugars, exercise regularly, and limit alcohol. Work with your doctor to monitor liver function with blood tests and ultrasounds. New treatments like pleiotrophin-blocking drugs may become available in the future.
Want to Apply This Research?
- Track weekly weight, waist circumference, and energy levels. Users can also log diet quality (servings of vegetables, processed foods, added sugars) and exercise minutes to monitor lifestyle factors that affect liver health.
- Users can set goals to reduce processed food intake and increase physical activity, two proven ways to improve liver health. The app could provide meal ideas low in added sugars and fats, track daily steps or exercise, and send reminders about these protective behaviors.
- Over 3-6 months, users can track trends in weight, energy levels, and diet quality. For those with diagnosed fatty liver disease, regular check-ins with healthcare providers about liver function tests (ALT, AST) and ultrasound findings provide objective measures of improvement. The app could help users prepare for these appointments by summarizing their lifestyle data.
This article discusses early-stage research conducted in mice and does not represent approved medical treatments for humans. Pleiotrophin-blocking drugs do not currently exist for human use. If you have fatty liver disease or metabolic concerns, consult with your healthcare provider about evidence-based treatment options including lifestyle modifications and appropriate medical monitoring. This research is promising but requires further human studies before clinical application. Do not delay seeking medical care based on this information.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
